Africa: Two New Candidate Vaccines to Join Ebola Trial As Treatment Research Advances
[WHO] Expert groups convened by the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to the ongoing Tumaini clinical trial in the Democratic Republic of the Congo (DRC). The recommendation marks the first time vaccines specifically designed to protect against Bundibugyo virus, the virus responsible for the current outbreak, will be evaluated during an outbreak of the disease.
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
[Claude] Reports 2 and 3 both cover the WHO recommendation to add the Oxford and Moderna Bundibugyo vaccine candidates to the Tumaini trial, with Report 2 adding a death toll figure that doesn't conflict with
49m agoScore bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this